ask="N/A"
ask_size="N/A"
average_daily_volume="766316"
bid="N/A"
bid_size="N/A"
book_value="-0.413"
change="+0.001"
change_from_200_day_moving_average="-0.097"
change_from_50_day_moving_average="-0.062"
change_from_52_week_high="-0.899"
change_From_52_week_low="0.351"
change_in_percent="+0.148%"
close="0.611"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.083"
ebitda="-1.60M"
eps_estimate_current_year="-0.080"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.030"
ex_dividend_date="N/A"
float_shares="139010000"
high="0.635"
high_52_weeks="1.510"
last_trade_date="1/18/2017"
last_trade_price="0.611"
last_trade_size="100"
last_trade_time="4:02pm"
low="0.595"
low_52_weeks="0.260"
market_capitalization="95.01M"
moving_average_200_day="0.708"
moving_average_50_day="0.673"
name="Navidea Biopharmaceuticals
Inc"
notes="N/A"
one_year_target_price="1.250"
open="0.635"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-13.658%"
percent_change_from_50_day_moving_average="-9.257%"
percent_change_from_52_week_high="-59.536%"
percent_change_from_52_week_low="+135.000%"
previous_close="0.610"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="4.141"
revenue="22.91M"
shares_outstanding="155494000"
short_ratio="15.910"
stock_exchange="ASE"
symbol="NAVB"
volume="300994"
weeks_range_52="0.260 - 1.510"
